315-37-7 |
Delatestryl |
Testosterone heptanoate |
Androtardyl |
Testosterone enantate |
Testosterone heptylate |
Atlatest |
Testanthate |
Testinon |
Testoenant |
Testostroval |
Everone |
Orquisteron-E |
Exten test |
Depo-Testro Med |
Testosterone oenanthate |
Andropository |
Durathate |
Testenate |
Testosterone heptoate |
Reposo-TMD |
Primotestone |
Malogen L.A. |
DePatestrye |
Testosterone 17-enanthate |
NSC-17591 |
Malogen L.A.200 |
Reposo TMD |
Testonenant |
Ditate |
Andro L.A. 200 |
17-Hydroxyandrost-4-en-3-one, 17-heptanoate |
Delatest |
Testate |
Xyosted |
Testosterone, heptanoate |
Heptanoic acid, ester with testosterone |
17-((1-Oxoheptyl)oxy)androst-4-en-3-one |
17beta-Enanthoxyandrost-4-en-3-one |
4-Androsten-3-one 17beta-enanthate |
Androgyn L.A. |
Androst-4-en-3-one, 17-[(1-oxoheptyl)oxy]-, (17b)- |
Testosterone ethanate |
CCRIS 7082 |
DEA No. 4000 |
17beta-Hydroxyandrost-4-en-3-one enanthate |
EINECS 206-253-5 |
Androst-4-en-3-one, 17-((1-oxoheptyl)oxy)-, (17beta)- |
Testosterone enanthate ciii |
BRN 3170544 |
CHEBI:9464 |
UNII-7Z6522T8N9 |
Testosterone enanthate [USP:JAN] |
Testosterone enanthate [USAN:JAN] |
Androst-4-en-3-one, 17beta-hydroxy-, heptanoate |
C26H40O3 |
7Z6522T8N9 |
[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] heptanoate |
Androst-4-en-3-one, 17-(1-oxoheptyl)oxy-, (17beta)- |
17-heptanoyl-17beta-hydroxyandrost-4-en-3-one |
4-08-00-00979 (Beilstein Handbook Reference) |
Theramex |
Androst-4-en-3-one, 17-[(1-oxoheptyl)oxy]-, (17.beta.)- |
17-[(1-Oxoheptyl)oxy]androst-4-en-3-one |
Androgyn L.A |
Malogen L.A |
Delatestryl (TN) |
Testosteroni enantas |
Ditate (Salt/Mix) |
Deladumone (Salt/Mix) |
Testosterone heptoic acid |
Enanthic acid testosterone |
SCHEMBL42687 |
Androgyn L.A. (Salt/Mix) |
Testosterone 17beta-heptanoate |
CHEMBL1200335 |
Androst-4-en-3-one, heptanoate |
DTXSID701016540 |
Testosterone 17beta-heptanoic acid |
TESTOSTERONE ENANTHATE [MI] |
DRG-0260 |
NSC17591 |
Testosterone enanthate (JP17/USP) |
TESTOSTERONE ENANTHATE [JAN] |
LMST02020075 |
s3717 |
Androst-4-en-3-one,(17.beta.)- |
TESTOSTERONE ENANTATE [MART.] |
TESTOSTERONE ENANTHATE [VANDF] |
AKOS015960945 |
TESTOSTERONE ENANTATE [WHO-IP] |
CCG-268655 |
CS-O-05333 |
DB13944 |
TESTOSTERONE ENANTHATE [USP-RS] |
TESTOSTERONE ENANTHATE [WHO-DD] |
4-Androsten-3-one 17.beta.-enanthate |
3-oxoandrost-4-en-17beta-yl heptanoate |
(8R,9S,10R,13S,14S,17S)-10,13-Dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl heptanoate |
AC-12599 |
DS-11585 |
Testosterone enanthate, analytical standard |
4-Androsten-17beta-ol-3-one 17-enanthate |
LS-148818 |
TESTOSTERONE ENANTATE [EP MONOGRAPH] |
TESTOSTERONE ENANTHATE [ORANGE BOOK] |
TESTOSTERONI ENANTAS [WHO-IP LATIN] |
17beta-hydroxyandrost-4-en-3-one heptanoate |
TESTOSTERONE ENANTHATE CIII [USP-RS] |
TESTOSTERONE ENANTHATE [USP MONOGRAPH] |
WLN: L E5 B666 OV MUTJ A E FOV6 |
C08157 |
D00958 |
DITATE-DS COMPONENT TESTOSTERONE ENANTHATE |
17-Hydroxyandrost-4-en-3-one, 17-heptanoic acid |
SR-01000942262 |
SR-01000942262-1 |
TESTOSTERONE ENANTHATE COMPONENT OF DITATE-DS |
W-106891 |
Androst-4-en-3-one, 17.beta.-hydroxy-, heptanoate |
Q27108402 |
3-Oxoandrost-4-en-17-yl heptanoate, (17.beta.)- # |
17.BETA.-(HEPTANOYLOXY)ANDROST-4-EN-3-ONE [WHO-IP] |
Androst-4-en-3-ona, 17-[(1-oxoheptil)oxi]-, (17beta )- |
ANDROST-4-EN-3-ONE, 17-(1-OXOHEPTYL)OXY-, (17.BETA.)- |
Testosterone enantate, European Pharmacopoeia (EP) Reference Standard |
Testosterone enanthate, United States Pharmacopeia (USP) Reference Standard |
Testosterone enantate for peak identification, European Pharmacopoeia (EP) Reference Standard |
Testosterone enantate for system suitability, European Pharmacopoeia (EP) Reference Standard |
There are more than 10 synonyms. If you wish to see them all click here.
|